|
Market Closed -
Euronext Paris
20:55:00 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.4500 EUR | -4.26% |
|
-22.28% | -61.80% |
| 10-22 | NFL Biosciences SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-22 | NFL Biosciences Gets Regulatory Approvals to Begin Phase 2 Nicotine Cessation Trial for NFL-102 | MT |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NFL BIOSCIENCES | Bio Therapeutic Drugs | -4.26% | -22.28% | -61.80% | -60.66% | -88.64% | 6.66M |  | | |
- Stock Market
- Stocks
- ALNFL Stock
- Charts NFL Biosciences
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
